Elevance Health, Inc. Long Term Debt

• Elevance Health, Inc. showed an increase of +5.4% in Long Term Debt from 2024 to 2025.
• This data is from Elevance Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2009: $8.51 billion | Q3 2009: $8.38 billion | Q1 2010: $7.63 billion | Q3 2010: $8.22 billion | Q1 2011: $8.54 billion | Q2 2011: $8.29 billion | Q3 2011: $8.62 billion | Q1 2012: $8.46 billion | Q2 2012: $10.14 billion | Q3 2012: $13.40 billion | Q1 2013: $14.03 billion | Q2 2013: $14.09 billion | Q3 2013: $14.51 billion | Q1 2014: $13.93 billion | Q2 2014: $14.04 billion | Q3 2014: $14.54 billion | Q1 2015: $14.76 billion | Q2 2015: $15.47 billion | Q3 2015: $15.72 billion | Q1 2016: $14.86 billion | Q2 2016: $14.20 billion | Q3 2016: $14.24 billion | Q1 2017: $15.45 billion | Q2 2017: $15.09 billion | Q3 2017: $13.78 billion | Q1 2018: $18.11 billion | Q2 2018: $17.52 billion | Q3 2018: $17.30 billion | Q1 2019: $17.40 billion | Q2 2019: $17.44 billion | Q3 2019: $18.82 billion | Q1 2020: $19.01 billion | Q2 2020: $19.87 billion | Q3 2020: $19.09 billion | Q1 2021: $22.53 billion | Q2 2021: $22.22 billion | Q3 2021: $21.76 billion | Q4 2021: $21.16 billion | Q1 2022: $19.88 billion | Q2 2022: $21.17 billion | Q3 2022: $21.26 billion | Q1 2023: $25.20 billion | Q2 2023: $24.86 billion | Q3 2023: $24.05 billion | Q1 2024: $21.98 billion | Q2 2024: $24.56 billion | Q3 2024: $24.69 billion | Q1 2025: $28.11 billion | Q2 2025: $28.18 billion | Q3 2025: $31.17 billion.
• Over the full 18 years of available data (2008 to 2025), Elevance Health, Inc.'s Long Term Debt has grown by 293.1%.
• Historical annual values: Fiscal year 2025: $30.80 billion | Fiscal year 2024: $29.22 billion | Fiscal year 2023: $23.25 billion | Fiscal year 2022: $22.35 billion | Fiscal year 2021: $21.16 billion | Fiscal year 2020: $19.34 billion | Fiscal year 2019: $17.79 billion | Fiscal year 2018: $17.22 billion | Fiscal year 2017: $17.38 billion | Fiscal year 2016: $14.36 billion | Fiscal year 2015: $15.32 billion | Fiscal year 2014: $14.02 billion | Fiscal year 2013: $13.57 billion | Fiscal year 2012: $14.17 billion | Fiscal year 2011: $8.47 billion | Fiscal year 2010: $8.15 billion | Fiscal year 2009: $8.34 billion | Fiscal year 2008: $7.83 billion.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026